Biofilms and chronic rhinosinusitis: Systematic review of evidence, current concepts and directions for research

Rhinology

Volumn 45, Issue 1, 2007, Pages 3-13

  Harvey, Richard J ^a,b   Lund, V J ^a  

^a ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Biofilm; Chronic; Chronic rhinosinusitis; Sinusitis; Systematic review

Indexed keywords

BIOFILM; CHRONIC DISEASE; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; NOSE MUCOSA; RESPIRATORY TRACT MUCOSA; REVIEW; RHINITIS; SINUSITIS;

BIOFILMS; CHRONIC DISEASE; HUMANS; NASAL MUCOSA; RESPIRATORY MUCOSA; RHINITIS; SINUSITIS;

EID: 33947635022     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-1322.
2. Hayes GW, Keating CL, Newman JS. The golden anniversary of the silver bullet. Jama 1993; 270: 1610-1611.
3. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997; 117: S1-7.
4. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop G, World Health O. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: S147-334.
5. Fokkens W, Lund V, Bachert C, Clement P, Hellings P. European position paper on rhinosinusitis and nasal polyps. Rhinology 2005; Supplement 18: 1-87.
6. Karlsson G, Holmberg K. Does allergic rhinitis predispose to sinusitis? Acta Oto-Laryngologica. Supplement 1994; 515: 26-29.
7. Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003; 129 (Suppl): S1-32.
8. Roitt IM, Brostoff J, Male DK. Immunology. 5th ed. London: Mosby 1998.
9. Post JC, Stoodley P, Hall-Stoodley L, Ehrlich GD. The role of biofilms in otolaryngologic infections. Curr Opin Otolaryngol Head Neck Sur 2004; 12: 185-190.
10. Tonnaer EL, Graamans K, Sanders EA, Curfs JH, Tonnaer ELGM, Graamans K, et al. Advances in understanding the pathogenesis of pneumococcal otitis media. Pediatr Infect Dis J 2006; 25: 546-552.
11. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. Jama 2006; 296: 202-211.
12. Hall-Stoodley L, Stoodley P. Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol 2005; 13: 7-10. [erratum in Trends Microbiol. 2005;13: 300-301].
13. Sanglard D. Resistance of human fungal pathogens to antifungal drugs. Curr Opin Microbiol 2002; 5: 379-385.
14. Westall F, de Wit MJ, Dann J, van der Gaast S, de Ronde CEJ, Gerneke D. Early Archean fossil bacteria and biofilms in hydrothermally-influenced sediments from the Barberton greenstone belt, South Africa. Precambrian Res 2001; 106: 93-116.
15. Rasmussen B. Filamentous microfossils in a 3,235-million-year-old volcanogenic massive sulphide deposit. Nature 2000; 405: 676-679.
16. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004; 2: 95-108.
17. Baty AM, 3rd, Eastburn CC, Techkarnjanaruk S, Goodman AE, Geesey GG. Spatial and temporal variations in chitinolytic gene expression and bacterial biomass production during chitin degradation. Appl Environ Microbiol 2000; 66: 3574-3585.
18. Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Ann Rev Microbiol 2002; 56: 187-209.
19. Costerton JW, Geesey GG, Cheng KJ. How bacteria stick. Sci Am 1978; 238: 86-95.
20. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-193.
21. Ring ME. Antoni van Leeuwenhoek and the tooth-worm. J Am Dent Assoc 1971; 83: 999-1001.
22. Parsek MR, Singh PK. Bacterial Biofilms: An Emerging Link to Disease Pathogenesis. Ann Rev Microbiol 2003; 57: 677-701.
23. Lawrence JR, Korber DR, Hoyle BD, Costerton JW, Caldwell DE, Lawrence JR, et al. Optical sectioning of microbial biofilms. J Bacteriol 1991; 173: 6558-6567.
24. Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G, et al. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 2003; 112: 1466-1477.
25. Lam J, Chan R, Lam K, Costerton JW. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 1980; 28: 546-556.
26. Stoodley P, DeBeer D, Lewandowski Z. Liquid flow in biofilm systems. Appl Environ Microbiol 1994; 60: 2711-2716.
27. Nataro JP, Blaser MJ, Cunningham-Rundles S. Persistent bacterial infections. Washington, DC: ASM Press 2000.
28. Sutherland IW. Exopolysaccharides in biofilms, flocs and related structures. Water Sci Technol 2001; 143: 77-86.
29. Sutherland IW. The biofilm matrix - an immobilized but dynamic microbial environment. Trends Microbiol 2001; 9: 222-227.
30. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial biofilm formation. Science 2002; 295: 1487.
31. Webb JS, Thompson LS, James S, Charlton T, Tolker-Nielsen T, Koch B, et al. Cell death in Pseudomonas aeruginosa biofilm development. J Bacteriol 2003; 185: 4585-4592.
32. Brown MRW, Allison DG, Gilbert P. Resistance of bacterial biofilms to antibiotics: A growth-rate related effect? J Antimicrob Chemother 1988; 22: 777-780.
33. Bagge N, Hentzer M, Andersen JB, Ciofu O, Givskov M, Hoiby N. Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2004; 48: 1168-1174.
34. Walters MC, 3rd, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 2003; 47: 317-323.
35. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol. 2002; 184: 1140-1154.
36. Waite RD, Papakonstantinopoulou A, Littler E, Curtis MA. Transcriptome analysis of Pseudomonas aeruginosa growth: comparison of gene expression in planktonic cultures and developing and mature biofilms. J Bacteriol 2005; 187: 6571-6576.
37. Waite RD, Paccanaro A, Papakonstantinopoulou A, Hurst JM, Saqi M, Littler E, et al. Clustering of Pseudomonas aeruginosa transcriptomes from planktonic cultures, developing and mature biofilms reveals distinct expression profiles. BMC Genomics 2006; 7: 162.
38. Wagner VE, Bushnell D, Passador L, Brooks AI, Iglewski BH. Microarray analysis of Pseudomonas aeruginosaquorum-sensing regulons: effects of growth phase and environment. J Bacteriol 2003;185: 2080-2095.
39. Resch A, Rosenstein R, Nerz C, Gotz F. Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol 2005; 71: 2663-2676.
40. Deziel E, Comeau Y, Villemur R. Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities. J Bacteriol 2001; 183: 1195-1204.
41. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998; 280: 295-298.
42. Whitchurch CB, Alm RA, Mattick JS. The alginate regulator AlgR and an associated sensor FimS are required for twitching motility in Pseudomonas aeruginosa. Proc Natl Acad Sci USA 1996; 93: 9839-9843.
43. Gerke C, Kraft A, Sussmuth R, Schweitzer O, Gotz F. Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J Biol Chem 1998; 273: 18586-18593.
44. Palmer J. Bacterial biofilms in chronic rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 2006; 196: 35-39.
45. O'Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 1998; 30: 295-304.
46. Davies DG, Geesey GG. Regulation of the alginate biosynthesis gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture. Appl Environ Microbiol 1995; 61: 860-867.
47. Boyd A, Chakrabarty AM. Role of alginate lyase in cell detachment of Pseudomonas aeruginosa. Appl Environ Microbiol 1994; 60: 2355-2359.
48. Lee SF, Li YH, Bowden GH. Detachment of Streptococcus mutans biofilm cells by an endogenous enzymatic activity. Infect Immun. 1996; 64: 1035-1038.
49. Baty 3rd AM, Eastburn CC, Diwu Z, Techkarnjanaruk S, Goodman AE, Geesey GG. Differentiation of chitinase-active and non-chitinase-active subpopulations of a marine bacterium during chitin degradation. Appl Environ Microbiol 2000; 66: 3566-3573.
50. Cramton SE, Gerke C, Schnell NF, Nichols WW, Gotz F. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun 1999; 67: 5427-5433.
51. Cucarella C, Solano C, Valle J, Amorena B, Lasa I, Penades JR. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol 2001; 183: 2888-2896.
52. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 2005; 13: 34-40.
53. Mahenthiralingam E, Campbell ME, Speert DP. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 1994; 62: 596-605.
54. Feltman H, Schulert G, Khan S, Jain M, Peterson L, Hauser AR. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiol 2001; 147: 2659-2669.
55. Furukawa S, Kuchma SL, O'Toole GA. Keeping their options open: acute versus persistent infections. J Bacteriol 2006; 188: 1211-1217.
56. Moser C, Kjaergaard S, Pressler T, Kharazmi A, Koch C, Hoiby N. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS 2000; 108: 329-335.
57. Brown MRW, Gilbert P. Sensitivity of biofilms to antimicrobial agents. J Appl Bacteriol Symp Suppl. 1993: 87S-97S.
58. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987; 41: 435-464.
59. Kumon H, Tomochika KI, Matunaga T, Ogawa M, Ohmori H. A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides. Microbiol Immunol 1994; 38: 615-619.
60. Stewart PS. A review of experimental measurements of effective diffusive permeabilities and effective diffusion coefficients in biofilms. Biotechnol Bioengineer 1998; 59: 261-272.
61. Anderl JN, Zahller J, Roe F, Stewart PS. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2003; 47: 1251-1256.
62. Konig C, Schwank S, Blaser J. Factors compromising antibiotic activity against biofilms of Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis 2001; 20: 20-26.
63. De Beer D, Stoodley P, Lewandowski Z. Measurement of local diffusion coefficients in biofilms by microinjection and confocal microscopy. Biotechnol Bioengineer 1997; 53: 151-158.
64. Stewart PS, Roe F, Rayner J, Elkins JG, Lewandowski Z, Ochsner UA, et al. Effect of catalase on hydrogen peroxide penetration into Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2000; 66: 836-838.
65. Jensen ET, Kharazmi A, Lam K, Costerton JW, Hoiby N. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms. Infect Immun 1990; 58: 2383-2385.
66. Leid JG, Shirtliff ME, Costerton JW, Stoodley AP. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 2002; 70: 6339-6345.
67. De Beer D, Srinivasan R, Stewart PS. Direct measurement of chlorine penetration into biofilms during disinfection. Appl Environ Microbiol 1994; 60: 4339-4344.
68. Das JR, Bhakoo M, Jones MV, Gilbert P. Changes in the biocide susceptibility of Staphylococcus epidermidis and Escherichia coli cells associated with rapid attachment to plastic surfaces. J Appl Microbiol 1998; 84: 852-858.
69. Cochran WL, McFeters GA, Stewart PS. Reduced susceptibility of thin Pseudomonas aeruginosa biofilms to hydrogen peroxide and monochloramine. J Appl Microbiol 2000; 88: 22-30.
70. Hausner M, Wuertz S. High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl Environ Microbiol 1999; 65: 3710-3713.
71. Gafan GP, Spratt DA. Denaturing gradient gel electrophoresis gel expansion (DGGEGE) - an attempt to resolve the limitations of co-migration in the DGGE of complex polymicrobial communities. FEMS Microbiol Lett 2005; 253: 303-307.
72. Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersboll BK, et al. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiol 2000; 146: 2395-2407.
73. Beyenal H, Donovan C, Lewandowski Z, Harkin G. Three-dimensional biofilm structure quantification. J Microbiol Methods 2004; 59: 395-413.
74. Cryer J, Schipor I, Perloff JR, Palmer JN. Evidence of bacterial biofilms in human chronic sinusitis. ORL J Otorhinolaryngol Relat Spec 2004; 66: 155-158.
75. Ferguson BJ, Seiden AM. Chronic rhinosinusitis. Otolaryngol Clin North Am 2005; 38: xiii-xv.
76. Ferguson BJ, Stolz DB. Demonstration of biofilm in human bacterial chronic rhinosinusitis. Am J Rhinol 2005; 19: 452-457.
77. Palmer JN. Bacterial biofilms: do they play a role in chronic sinusitis? Otolaryngol Clin North Am 2005; 38: 1193-1201.
78. Ramadan HH, Sanclement JA, Thomas JG. Chronic rhinosinusitis and biofilms. Otolaryngol Head Neck Surg 2005; 132: 414-417.
79. Sanclement JA, Webster P, Thomas J, Ramadan HH. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 2005; 115: 578-582.
80. Zuliani G, Carron M, Gurrola J, Coleman C, Haupert M, Berk R, et al. Identification of adenoid biofilms in chronic rhinosinusitis. Int J Pediatr Otorhinolaryngol 2006; 70: 1613-1617.
81. Perloff JR, Palmer JN. Evidence of bacterial biofilms in a rabbit model of sinusitis. Am J Rhinol 2005; 19: 1-6.
82. Sanderson AR, Leid JG, Hunsaker D. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope 2006; 116: 1121-1126.
83. Bendouah Z, Barbeau J, Hamad WA, Desrosiers M. Use of an in vitro assay for determination of biofilm-forming capacity of bacteria in chronic rhinosinusitis. Am J Rhinol 2006; 20: 434-438.
84. Bendouah Z, Barbeau J, Hamad WA, Desrosiers M. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 2006; 134: 991-996.
85. Perloff JR, Palmer JN. Evidence of bacterial biofilms on frontal recess stents in patients with chronic rhinosinusitis. Am J Rhinol 2004; 18: 377-380.
86. Ramadan HH. Chronic rhinosinusitis and bacterial biofilms. Curr Opin Otolaryngol Head Neck Surg 2006; 14: 183-186.
87. Dohar JE, Hebda PA, Veeh R, Awad M, Costerton JW, Hayes J, et al. Mucosal biofilm formation on middle-ear mucosa in a nonhuman primate model of chronic suppurative otitis media. Laryngoscope 2005; 115: 1469-1472.
88. Klapper I, Rupp CJ, Cargo R, Purvedorj B, Stoodley P. Viscoelastic fluid description of bacterial biofilm material properties. Biotechnol Bioengineer 2002; 80: 289-296.
89. Schlosser RJ. Surfactant and its role in chronic sinusitis. Ann Otol Rhinol Laryngol Suppl 2006; 196: 40-44.
90. Woodworth BA, Smythe N, Spicer SS, Schulte BA, Schlosser RJ. Presence of surfactant lamellar bodies in normal and diseased sinus mucosa. ORL J Otorhinolaryngol Relat Spec 2005; 67: 199-202.
91. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR, et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 2004; 6: 269-275.
92. Costerton JW, Ellis B, Lam K, Johnson F, Khoury AE. Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria. Antimicrob Agents Chemother 1994; 38: 2803-2809.
93. Wattanakaroon W, Stewart PS. Electrical enhancement of Streptococcus gordonii biofilm killing by gentamicin. Arch Oral Biol 2000; 45: 167-171.
94. Pitt WG, McBride MO, Lunceford JK, Roper RJ, Sagers RD, Pitt WG, et al. Ultrasonic enhancement of antibiotic action on gram-negative bacteria. Antimicrob Agents Chemother. 1994; 38: 2577-2582.
95. Rediske AM, Roeder BL, Brown MK, Nelson JL, Robison RL, Draper DO, et al. Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: an in vivo model. Antimicrob Agents Chemother 1999; 43: 1211-1214.
96. Dunne WM, Jr., Burd EM. The effects of magnesium, calcium, EDTA, and pH on the in vitro adhesion of Staphylococcus epidermidis to plastic. Microbiol Immunol 1992; 36: 1019-1027.
97. Henrickson KJ, Dunne WM, Jr. Modification of central venous catheter flush solution improves in vitro antimicrobial activity. J Infect Dis 1992; 166: 944-946.
98. Hentzer M, Eberl L, Nielsen J, Givskov M. Quorum sensing: a novel target for the treatment of biofilm infections. Biodrugs 2003; 17: 241-250.
99. Stephenson K, Hoch JA. Developing inhibitors to selectively target two-component and phosphorelay signal transduction systems of pathogenic microorganisms. Curr Med Chem 2004; 11: 765-773.
100. Spoering AL, Gilmore MS. Quorum sensing and DNA release in bacterial biofilms. Curr Opin Microbiol 2006; 9: 133-137.
101. March JC, Bentley WE. Quorum sensing and bacterial cross-talk in biotechnology. Curr Opin Biotechnol 2004; 15: 495-502.
102. Chen X, Schauder S, Potier N, Van Dorsselaer A, Pelczer I, Bassler BL, et al. Structural identification of a bacterial quorum-sensing signal containing boron.[see comment]. Nature 2002; 415: 545-549.
103. Balaban N, Giacometti A, Cirioni O, Gov Y, Ghiselli R, Mocchegiani F, et al. Use of the quorum-sensing inhibitor RNAI-II-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J Infect Dis 2003; 187: 625-630.
104. Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell'Acqua G, et al. Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP. Clin Orthop 2005; 437: 48-54.
105. Dell'Acqua G, Giacometti A, Cirioni O, Ghiselli R, Saba V, Scalise G, et al. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. J Infect Dis 2004; 190: 318-320.
106. Von Bodman SB, Bauer WD, Coplin DL. Quorum sensing in plant-pathogenic bacteria. Ann Rev Phytopathol 2003; 41: 455-482.